MEDICA 20 20
conscious with a vast amount of data on a wide variety of parameters. The sports doctor Prof. Billy Sperlich of the University of Würzburg will explain how this personal data can be utilised by athletes and patients in the rehabilitation sector.
The question arises: how can the complexity inherent in these growing data volumes be simplified? This biostatistical question will be explored by Prof. Frank Klawonn, of the Helmholtz Centre for Infection Research (HZI) in Brunswick. The European Union has issued a regulation on the usage of in-vitro diagnostic medical devices. After a transition period of five years, all medical products, including software products, must undergo mandatory quality tests from 2022 onwards. The essential aspects of this regulation are presented by Dr. Sebastian Grömminger of the Johner Institute in Konstanz. The Medica Labmed Forum will further explore oncology, focussing on blood analysis. In his talk, Dr. Frank Diehl, a scientific advisor from Hamburg, will look at new developments in examining circulating tumour DNA (ctDNA) in blood plasma, which is used to detect tumours at an early stage. NGS deep sequencing, in combination with tumour-associated proteins, play an increasingly important role in evidencing a number of tumour-specific mutations and epigenetic changes in ctDNA. Dr. Niroshan Nadarajah, a computational biology specialist from the Munich
Leukaemia Laboratory (MLL), discusses the opportunities for improving leukaemia diagnostics using artificial intelligence, undertaking better classification using gradual differentiations and increasing prognostic validity. Prof. Dr. Michiel Pegtel, head of the liquid biopsy centre at the University of Amsterdam, concentrates on extracellular vesicles and exosomes which are emitted into the surrounding environment by tumour cells in his presentation. He will investigate the question of how this reflects the tumour’s biology and how it can be employed for cancer diagnostics and therapy. Prof. Bernd. Giebel, from the University of Essen, will expand on this topic and illustrate new therapeutical approaches in immunomodulation with the help of exosomes obtained from stem cells.
Day 3: The central role of laboratory medicine in the COVID-19 pandemic The diagnostic and clinical aspects of the COVID-19 pandemic will be the focus of the sessions on Wednesday 18 November. The presentations (from 12 p.m. onwards) are chaired by Prof. Gunther Hartmann of the University of Bonn, and will concentrate on COVID-19 diagnostics, mass screening of the population and quality control. The sessions will also investigate new developments in COVID-19 testing technology and current options for testing immunity to the SARS- CoV-2 virus.
The role of laboratory medicine diagnostics Disruptive healthcare innovations
The MEDICA Connected Healthcare Forum is the innovation and networking forum for the healthcare industry, where international companies and start-ups present their latest insights, technologies and solutions for connected and mobile healthcare. More
than 130 speakers will show which digital topics will be on the future health agenda. In the ‘MEDICA Disrupt’ sessions, around 100 selected start-ups will present solutions that are expected to revolutionise healthcare. The forum language is English.
36 l
WWW.CLINICALSERVICESJOURNAL.COM
in monitoring the course of COVID-19 infections and in estimating the incidence of severe cases will also be illuminated. Findings on patients’ genetic susceptibility to having a severe case of COVID-19 will also be a subject of discussion, along with models which show how potential (local) overload of the healthcare system can be forecasted.
Day 4: Young scientists and laboratory medicine specialists meet innovative industry At the end of this forum, two worlds will be brought together. Young scientists and laboratory medicine specialists will report on their research projects on biobanking, liquid biopsy and other trends in laboratory medicine and diagnostic companies will present innovative test procedures for COVID-19 on 19 November. This day will be hosted by the German Society for Clinical Chemistry and Laboratory Medicine (DGKL, Young Laboratory Division) and the Diagnostics Industry Association (VDGH, Life Science Research Group). The complete programme for virtual. MEDICA 2020 (16 – 19 November) can be viewed online.
CSJ Register at:
https://virtual.MEDICA.de. MEDICA 2021 and
COMPAMED 2021 MEDICA is the world’s largest event for the medical sector and attracts several thousand exhibitors from more than 50 countries in the halls. MEDICA 2021 and COMPAMED 2021 will be held as a hybrid event next year. The hybrid concept consists of combining live platforms for professional visitors to the Düsseldorf trade fair centre and digital offers.
NOVEMBER 2020
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100
